Status:
RECRUITING
Impact of Immune Status on Secondary Infections in Patients With Acute Respiratory Failure
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
ARDS
Eligibility:
All Genders
7+ years
Brief Summary
This is a retrospective observational study over the period 1/2019 - 02/2024 with the aim of identifying patients with a predisposition to secondary infections.
Detailed Description
As a reference center, Charité Universitaetsmedizin Berlin has been treating patients with the most severe form of acute respiratory failure, known as acute respiratory distress syndrome (ARDS), for m...
Eligibility Criteria
Inclusion
- Male and female acute respiratory distress syndrome patients who had an immune status within 48 h of admission
- Patients who received intensive care treatment for acute respiratory distress syndrome ward 8i at Charité in the period from 01/2019 to 02/2024 with a maximum follow-up period of 90 days
Exclusion
- None
Key Trial Info
Start Date :
July 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 22 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06511622
Start Date
July 10 2024
End Date
May 22 2025
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - University Medicine Berlin
Berlin, Germany, 10117